ProcureHub · Direct Materials · Global
Auto-injectors: Market Size & Forecast 2026
The global auto-injectors market reached approximately USD 4.5 billion in 2025 (base year), representing the device-only segment of a broader drug-device combination products category. We project the market to grow at a 6.2% CAGR through 2032, reaching approximately USD 6.9 billion by the forecast year. The market sits in a structurally tight supply position following the GLP-1 demand surge, with lead times for final assembly and sterile fill-finish extending to 18-24 months for high-volume biologic platforms. > **Analyst Take.** The Embecta-Owen Mumford deal is the single most consequential supply-chain event for 2026-2027. Owen Mumford brought the Aidaptus platform and an established CDMO relationship with Stevanato; combined with Embecta's insulin-pen manufacturing scale, the entity becomes a Tier-1 player overnight. Buyers currently single-sourced on Owen Mumford should negotiate a m
Official data · Claight AnalysisForecast
Market size and CAGR extracted from the published Claight report; figures match the report..
2025 base: $4.8bn2032 est: $7.3bn
Talk to a Claight analyst
Do you want to research Auto-injectors?
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.